Table 3.
Changes of total bands in control, and of polymorphic bands and varied bands in A.cepa cells exposed to Butylated hydroxyltoluene (BHT) and Butylated hydroxyanisole (BHA).
| primers | C | Treatments with BHT (ppm) |
Treatments with BHA (ppm) |
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1000 |
1500 |
2000 |
2500 |
1000 |
1500 |
2000 |
2500 |
||||||||||||||||||||||||||
| a | b | c | d | a | b | c | d | a | b | c | d | a | b | c | d | a | b | c | d | a | b | c | d | a | b | c | d | a | b | c | d | ||
| OPA-01 | 11 | 2 | 1 | 0 | 0 | 2 | 1 | 1 | 0 | 1 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| OPA-02 | 5 | 0 | 1 | 1 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 2 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 0 |
| OPA-03 | 8 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 0 |
| OPA-05 | 6 | 1 | 0 | 1 | 0 | 2 | 1 | 0 | 1 | 2 | 0 | 1 | 0 | 1 | 3 | 0 | 2 | 3 | 1 | 1 | 0 | 2 | 3 | 1 | 0 | 3 | 1 | 1 | 1 | 0 | 2 | 2 | 1 |
| OPA-07 | 13 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 2 | 3 | 2 | 3 | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 3 | 0 | 0 | 0 | 2 | 3 | 1 | 1 |
| OPA-09 | 5 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 1 | 3 | 1 | 1 | 0 | 1 | 2 | 1 | 0 | 1 | 0 | 1 | 0 | 2 | 1 | 0 | 1 | 2 | 3 | 1 | 1 | 3 | 2 | 2 | 2 |
| Total bands | 48 | ||||||||||||||||||||||||||||||||
| a+b | 8 | 11 | 13 | 13 | 10 | 11 | 15 | 15 | |||||||||||||||||||||||||
| a+b+c+d | 11 | 18 | 22 | 22 | 14 | 15 | 19 | 26 | |||||||||||||||||||||||||
C: indicates control group, a: indicates appearance of new bands, b: disappearance of normal bands, c: decrease in band intensities, and d: increase in band intensities. a+b denotes polymorphic bands, a+b+c+d, varied band.